Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Myeloid 1Dermatologic 1

Conditions

Myelodysplastic Syndromes 7Leukemia, Myeloid, Acute 5Leukemia 3Urologic Neoplasms 1Thyroid Neoplasms 1Soft Tissue Neoplasms 1Sarcoma 1Recurrence 1Pharyngeal Neoplasms 1Neurofibromatosis 2 1Neoplasms, Mesothelial 1Neoplasms 1Neoplasm Metastasis 1Mouth Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma 1Lymphangioleiomyomatosis 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hodgkin Disease 1Hematologic Neoplasms 1Erdheim-Chester Disease 1Endocrine Gland Neoplasms 1Castleman Disease 1Carcinoma, Transitional Cell 1Breast Neoplasms 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Cyclophosphamide 102fludarabine phosphate 94Mycophenolic Acid 81Tacrolimus 70Whole-Body Irradiation 65Peripheral Blood Stem Cell Transplantation 65fludarabine 49Busulfan 49Cyclosporine 48Antilymphocyte Serum 44Melphalan 39Filgrastim 37Methotrexate 32Radiotherapy 25Granulocyte Colony-Stimulating Factor 22Cord Blood Stem Cell Transplantation 20Sirolimus 19Rituximab 19thymoglobulin 18Stem Cell Transplantation 18Methylprednisolone 16Alemtuzumab 16Thiotepa 13sargramostim 11Cytarabine 11Cyclosporins 11Clofarabine 11Therapeutics 10Flow Cytometry 10Etoposide 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hodgkin Disease × Valproic Acid × Myeloid × Clear all
NCT03885947 2021-05-24

VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies

Icahn School of Medicine at Mount Sinai

Phase 1 Completed
7 enrolled
LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡